CD Genomics Accelerates RNA Research with the Launch of Nanopore Direct Sequencing

CD Genomics, a global leader in transcriptomics solutions, unveils its mature Nanopore Direct RNA Sequencing service that can propel transcriptomics research to new heights. With this service, CD Genomics empowers researchers to unlock the full potential of their studies with unrivalled precision and efficiency.

Harnessing the power of Oxford Nanopore sequencing technology, this revolutionary platform enables real-time analysis of RNA molecules without the need for cumbersome reverse transcription and amplification steps. Direct sequencing provides researchers with a comprehensive and unbiased view of the transcriptome, capturing even the rarest and low-abundance transcripts previously overlooked. Novel gene isoforms, non-coding RNAs, and RNA modifications can now be unveiled, paving the way for groundbreaking discoveries across various biological processes.

Nanopore Direct RNA Sequencing offers exceptional long-read capabilities, allowing the sequencing of full-length RNA transcripts without the need for assembly. By spanning entire RNA molecules, scientists gain invaluable insights into alternative splicing events, structural variations, and intricate regulatory mechanisms driving gene expression. This unprecedented level of detail revolutionizes our understanding of RNA biology and holds immense promise for fields such as cancer research, developmental biology, neurobiology, and infectious disease studies.

CD Genomics stands alongside researchers, providing comprehensive support throughout the scientific journey. With Nanopore Direct RNA Sequencing, the team of expert scientists and bioinformaticians delivers end-to-end solutions, encompassing optimized sample preparation and in-depth data analysis. By ensuring high-quality results and actionable insights, CD Genomics empowers researchers to confidently navigate the complexities of their experiments.

Key features of Nanopore Direct RNA Sequencing:

• Unbiased and comprehensive analysis: Researchers can obtain a complete and unbiased view of RNA populations, including rare and low-abundance transcripts, for a comprehensive understanding of gene expression profiles.
• Long-read capabilities: The platform seamlessly sequences full-length RNA transcripts without the need for assembly, enabling the detection of alternative splicing events and structural variations.
• Real-time analysis: Immediate insights into RNA sequences enable rapid decision-making and accelerate scientific discoveries.
• Streamlined workflow: The elimination of time-consuming reverse transcription and amplification steps reduces experimental time and cost.

“Nanopore Direct RNA Sequencing represents a significant leap forward in RNA analysis. By eliminating the need for reverse transcription and amplification steps, we provide researchers with a direct and comprehensive view of the transcriptome, enabling the discovery of rare and low-abundance transcripts that were previously challenging to detect.” stated CD Genomics’ senior scientist.

About CD Genomics

CD Genomics is a genomics service provider well-known for providing reliable sequencing and bioinformatics analysis services, aiming to deliver high-quality next-generation sequencing, third-generation sequencing, and microarray services for the research community.

Contact

Address: Shirley, NY 11967, USA

Email: contact@cd-genomics.com